Why invest in us

Distressingly, pancreatic ductal adenocarcinoma (PDAC) is inexorably on the rise in the 7MM and is projected to become the second leading cause of cancer death in Western counties by 2030.

Consensus among major Investment Consultancies is that the global PDAC market size will grow at an impressive CAGR of between 13 and 15% and above, reaching revenues estimated at, or beyond, US$ 10 billions by 2036.

The pancreatic cancer market CAGR positions it as one of the fastest-growing segments in oncology, outpacing other major cancer markets.

Comparison with Other Cancer Markets


1. Lung Cancer Market: The lung cancer treatment market is expected to grow at a CAGR of around 9% to 10% over the next few years, which is lower than that of pancreatic cancer.
2. Breast Cancer Market: The breast cancer treatment market often exhibits a CAGR of about 7% to 8%, which also falls short compared to the pancreatic cancer market’s growth rate.
3. Colorectal Cancer Market: This market is projected to have a CAGR of approximately 8%, again indicating slower growth relative to pancreatic cancer.
4. Prostate Cancer Market: The prostate cancer treatment market typically sees a CAGR of about 6% to 8%, which is significantly lower than the pancreatic cancer market.

The rationale for this investment surge in PDAC treatments will be:

TAPCA aims to be to Go-to place for pancreatic cancer Public & Private Investors and for the Industry when it will matter, as we are the most advanced unified PDAC research hotspot in the world.

• Its world class investigators constitute de facto the most qualified R&D department ever created for pancreatic cancers.
• It allows for unmatched sharing of data/samples and for a considerable de-risking of its research projects.
• Each clinical trial will be run simultaneously in multiple transatlantic labs.
• It will leverage the World’s Largest Patients Registry in pancreatic cancer to supercharge its clinical trials.
• It allows for intense leveraging of its unrivaled expertise with the Industry, HTAs, Regulators and Policymakers.

TAPCA is synonym with

To reach out, please go to